Non-invasive SARS-CoV-2 RNA detection and human transcriptome analysis using skin surface lipids.
COVID-19
SARS-CoV-2
Sebum
Skin
Skin surface lipid
Transcriptome
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
30 10 2024
30 10 2024
Historique:
received:
14
06
2024
accepted:
25
10
2024
medline:
30
10
2024
pubmed:
30
10
2024
entrez:
30
10
2024
Statut:
epublish
Résumé
There have been several reports of skin manifestations in patients with coronavirus disease 2019 (COVID-19). However, it is unclear whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA can be detected on the skin surface, including the sebum, of these patients. In this study, SARS-CoV-2 RNA was detected using real-time reverse-transcription polymerase chain reaction (RT-PCR) assay of skin surface lipids (SSLs) collected using an oil-blotting film from the faces of hospitalized patients with COVID-19. Human transcriptome analysis was also performed using the same samples. In facial SSLs of patients with COVID-19, the RT-PCR positivity rate was 84.6% (11/13 samples) within 5 days and 30.4% (7/23 samples) by 6-10 days of symptom onset. In the transcriptome analysis, the most characteristic SSL-RNA profile was the upregulation of interferon-stimulated gene (ISG)-related genes, such as ISG15, IFITM1, and MX1. This study presents an alternative technique using SSLs for non-invasive SARS-CoV-2 RNA detection and simultaneous analysis of human molecular pathogenesis in patients with COVID-19.
Identifiants
pubmed: 39472469
doi: 10.1038/s41598-024-77862-0
pii: 10.1038/s41598-024-77862-0
doi:
Substances chimiques
RNA, Viral
0
Lipids
0
ISG15 protein, human
60267-61-0
Ubiquitins
0
Myxovirus Resistance Proteins
0
Cytokines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
26057Subventions
Organisme : Japan Agency for Medical Research and Development
ID : JP21fk0108104
Informations de copyright
© 2024. The Author(s).
Références
Wang, W. et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 323, 1843–1844 (2020).
pubmed: 32159775
Peng, L. et al. SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens. J. Med. Virol. 92, 1676–1680 (2020).
doi: 10.1002/jmv.25936
pubmed: 32330305
pmcid: 7264521
Wyllie, A. L. et al. Saliva or nasopharyngeal swab specimens for detection of SARS-CoV-2. N Engl. J. Med. 383, 1283–1286 (2020).
doi: 10.1056/NEJMc2016359
pubmed: 32857487
Matic, N. et al. Practical challenges to the clinical implementation of saliva for SARS-CoV-2 detection. Eur. J. Clin. Microbiol. Infect. Dis. 40, 447–450 (2021).
doi: 10.1007/s10096-020-04090-5
pubmed: 33236269
Polly, S. & Fernandez, A. P. Common skin signs of COVID-19 in adults: An update. Cleve Clin. J. Med. 89, 161–167 (2022).
doi: 10.3949/ccjm.89a.21126
pubmed: 35232829
Majumdar, R. et al. SARS-CoV-2 RNA detection in formalin-fixed paraffin-embedded (FFPE) tissue by droplet digital PCR (ddPCR). Clin. Chim. Acta 532, 181–187 (2022).
doi: 10.1016/j.cca.2022.05.007
pubmed: 35550815
Marzano, A. V. et al. SARS-CoV-2 detection by digital polymerase chain reaction and immunohistochemistry in skin biopsies from 52 patients with different COVID-19-associated cutaneous phenotypes. Dermatology. 239, 584–591 (2023).
doi: 10.1159/000530746
pubmed: 37075721
Fathizadeh, H. et al. Study presence of COVID-19 (SARS-CoV-2) in the sweat of patients infected with COVID-19. Microb. Pathog 149, 104556 (2020).
doi: 10.1016/j.micpath.2020.104556
pubmed: 33031898
pmcid: 7534876
Arslan, B., Bercin, S., Aydogan, S., Islamoglu, Y. & Dinc, B. SARS-CoV-2 is not found in the sweat of COVID-19 positive patients. Ir. J. Med. Sci. 191, 27–29 (2022).
doi: 10.1007/s11845-021-02537-y
pubmed: 33580478
Recalcati, S., Tonolo, S., Meroni, E. & Fantini, F. SARS-CoV-2 in the sweat of COVID-19-positive patients: A possible route of transmission? J. Eur. Acad. Dermatol. Venereol. 35, e865–e866 (2021).
doi: 10.1111/jdv.17607
pubmed: 34416062
pmcid: 8656368
Inoue, T. et al. Non-invasive human skin transcriptome analysis using mRNA in skin surface lipids. Commun. Biol. 5, 215 (2022).
doi: 10.1038/s42003-022-03154-w
pubmed: 35264722
pmcid: 8907185
Shima, K. et al. Non-invasive transcriptomic analysis using mRNAs in skin surface lipids obtained from children with mild-to-moderate atopic dermatitis. J. Eur. Acad. Dermatol. Venereol. 36, 1477–1485 (2022).
doi: 10.1111/jdv.18173
pubmed: 35462437
pmcid: 9545805
Yamamoto-Hanada, K. et al. mRNAs in skin surface lipids unveiled atopic dermatitis at 1 month. J. Eur. Acad. Dermatol. Venereol. 37, 1385–1395 (2023).
doi: 10.1111/jdv.19017
pubmed: 36897437
Uehara, Y. et al. Non-invasive diagnostic tool for Parkinson’s disease by sebum RNA profile with machine learning. Sci. Rep. 11, 18550 (2021).
doi: 10.1038/s41598-021-98423-9
pubmed: 34545158
pmcid: 8452747
Song, M., Bai, H., Zhang, P., Zhou, X. & Ying, B. Promising applications of human-derived saliva biomarker testing in clinical diagnostics. Int. J. Oral Sci. 15, 2 (2023).
doi: 10.1038/s41368-022-00209-w
pubmed: 36596771
pmcid: 9810734
Frediani, J. K. et al. The new normal: Delayed peak SARS-CoV-2 viral loads relative to symptom onset and implications for COVID-19 testing programs. Clin. Infect. Dis. 78, 301–307 (2024).
doi: 10.1093/cid/ciad582
pubmed: 37768707
Puhach, O., Meyer, B. & Eckerle, I. SARS-CoV-2 viral load and shedding kinetics. Nat. Rev. Microbiol. 21, 147–161 (2023).
pubmed: 36460930
Sarkar, L., Liu, G. & Gack, M. U. ISG15: Its roles in SARS-CoV-2 and other viral infections. Trends Microbiol. 31, 1262–1275 (2023).
doi: 10.1016/j.tim.2023.07.006
pubmed: 37573184
Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718–724 (2020).
doi: 10.1126/science.abc6027
pubmed: 32661059
pmcid: 7402632
Domizio, J. D. et al. The cGAS-STING pathway drives type I IFN immunopathology in COVID-19. Nature 603, 145–151 (2022).
doi: 10.1038/s41586-022-04421-w
pubmed: 35045565
pmcid: 8891013
Ohue-Kitano, R. et al. Medium-chain fatty acids suppress lipotoxicity-induced hepatic fibrosis via the immunomodulating receptor GPR84. JCI Insight. 8, e165469 (2023).
doi: 10.1172/jci.insight.165469
pubmed: 36480287
pmcid: 9977302
Greenberg, E. et al. (ed, N.) Circadian control of interferon-sensitive gene expression in murine skin. Proc. Natl. Acad. Sci. U S A 117 5761–5771 (2020).
doi: 10.1073/pnas.1915773117
pubmed: 32132203
pmcid: 7084068
Shirato, K. et al. Development of genetic diagnostic methods for detection for novel coronavirus 2019(nCoV-2019) in Japan. Jpn J. Infect. Dis. 73, 304–307 (2020).
doi: 10.7883/yoken.JJID.2020.061
pubmed: 32074516
Itokawa, K., Sekizuka, T., Hashino, M., Tanaka, R. & Kuroda, M. Disentangling primer interactions improves SARS-CoV-2 genome sequencing by multiplex tiling PCR. PLoS One 15, e0239403 (2020).
doi: 10.1371/journal.pone.0239403
pubmed: 32946527
pmcid: 7500614
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
doi: 10.1186/s13059-014-0550-8
pubmed: 25516281
pmcid: 4302049
Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30 (2000).
doi: 10.1093/nar/28.1.27
pubmed: 10592173
pmcid: 102409
Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57 (2009).
doi: 10.1038/nprot.2008.211
pubmed: 19131956
Sherman, B. T. et al. A web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 50, W216–W221 (2022).
doi: 10.1093/nar/gkac194
pubmed: 35325185
pmcid: 9252805